Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
25
SMMNY Quote, Financials, Valuation and Earnings
Last price:
$20.74
Seasonality move
:
1.34%
Day range:
$20.46 - $20.84
52-week range:
$20.39 - $28.92
Dividend yield:
2.9%
P/E ratio:
19.21x
P/S ratio:
1.75x
P/B ratio:
2.12x
Volume:
117.6K
Avg. volume:
246.8K
1-year change:
-23.55%
Market cap:
$45.9B
Revenue:
$25.8B
EPS (TTM):
$1.07
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
-- | -- | -- | -- | -- |
|
BNTX
BioNTech SE
|
$201.5M | -$1.97 | -7.26% | -35.17% | $130.51 |
|
CVAC
CureVac NV
|
$15.4M | -$0.11 | 0.04% | -32.36% | $5.31 |
|
IFRX
InflaRx NV
|
$6.4K | -$0.14 | -74.55% | -23.33% | $8.84 |
|
IMTX
Immatics NV
|
$11.7M | -$0.46 | -40.34% | -26.23% | $18.75 |
|
MDGEF
Medigene AG
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
$20.74 | -- | $45.9B | 19.21x | $0.59 | 2.9% | 1.75x |
|
BNTX
BioNTech SE
|
$91.18 | $130.51 | $23.4B | 191.55x | $0.00 | 0% | 6.64x |
|
CVAC
CureVac NV
|
$4.66 | $5.31 | $1B | 6.52x | $0.00 | 0% | 12.94x |
|
IFRX
InflaRx NV
|
$0.91 | $8.84 | $66.6M | -- | $0.00 | 0% | 281.78x |
|
IMTX
Immatics NV
|
$10.35 | $18.75 | $1.4B | 42.21x | $0.00 | 0% | 24.29x |
|
MDGEF
Medigene AG
|
-- | -- | -- | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
44.32% | 1.071 | 29.26% | 0.62x |
|
BNTX
BioNTech SE
|
1.37% | 1.157 | 1.31% | 7.36x |
|
CVAC
CureVac NV
|
3.87% | 1.706 | 3.39% | 1.84x |
|
IFRX
InflaRx NV
|
2.1% | -3.295 | 1.26% | 2.34x |
|
IMTX
Immatics NV
|
3.13% | 2.015 | 1.3% | 11.05x |
|
MDGEF
Medigene AG
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
$2.4B | $842.7M | 6.27% | 11.6% | 13.4% | $353.8M |
|
BNTX
BioNTech SE
|
$668.2M | -$271M | -5.85% | -5.93% | -25.66% | $277M |
|
CVAC
CureVac NV
|
$57.9M | -$11.6M | 19.52% | 20.55% | -18.33% | $31.6M |
|
IFRX
InflaRx NV
|
-$89.2K | -$11.7M | -80.95% | -82.01% | -42057.91% | -$11.4M |
|
IMTX
Immatics NV
|
-- | -$50.7M | -38.67% | -40.01% | -220.36% | -$68.9M |
|
MDGEF
Medigene AG
|
-- | -- | -- | -- | -- | -- |
Siemens Healthineers AG vs. Competitors
-
Which has Higher Returns SMMNY or BNTX?
BioNTech SE has a net margin of 8.44% compared to Siemens Healthineers AG's net margin of -33.61%. Siemens Healthineers AG's return on equity of 11.6% beat BioNTech SE's return on equity of -5.93%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG38.43% $0.23 $38.9B BNTXBioNTech SE63.27% -$1.45 $22.9B -
What do Analysts Say About SMMNY or BNTX?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand BioNTech SE has an analysts' consensus of $130.51 which suggests that it could grow by 43.13%. Given that BioNTech SE has higher upside potential than Siemens Healthineers AG, analysts believe BioNTech SE is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 BNTXBioNTech SE13 5 0 -
Is SMMNY or BNTX More Risky?
Siemens Healthineers AG has a beta of 1.171, which suggesting that the stock is 17.066% more volatile than S&P 500. In comparison BioNTech SE has a beta of 1.581, suggesting its more volatile than the S&P 500 by 58.073%.
-
Which is a Better Dividend Stock SMMNY or BNTX?
Siemens Healthineers AG has a quarterly dividend of $0.59 per share corresponding to a yield of 2.9%. BioNTech SE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 34.75% of its earnings as a dividend. BioNTech SE pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or BNTX?
Siemens Healthineers AG quarterly revenues are $6.3B, which are larger than BioNTech SE quarterly revenues of $1.1B. Siemens Healthineers AG's net income of $530.8M is higher than BioNTech SE's net income of -$355M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 19.21x while BioNTech SE's PE ratio is 191.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 1.75x versus 6.64x for BioNTech SE. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG1.75x 19.21x $6.3B $530.8M BNTXBioNTech SE6.64x 191.55x $1.1B -$355M
-
Which has Higher Returns SMMNY or CVAC?
CureVac NV has a net margin of 8.44% compared to Siemens Healthineers AG's net margin of -5832.47%. Siemens Healthineers AG's return on equity of 11.6% beat CureVac NV's return on equity of 20.55%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG38.43% $0.23 $38.9B CVACCureVac NV91.57% $1.41 $1.1B -
What do Analysts Say About SMMNY or CVAC?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand CureVac NV has an analysts' consensus of $5.31 which suggests that it could grow by 14.28%. Given that CureVac NV has higher upside potential than Siemens Healthineers AG, analysts believe CureVac NV is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 CVACCureVac NV1 3 0 -
Is SMMNY or CVAC More Risky?
Siemens Healthineers AG has a beta of 1.171, which suggesting that the stock is 17.066% more volatile than S&P 500. In comparison CureVac NV has a beta of 1.801, suggesting its more volatile than the S&P 500 by 80.137%.
-
Which is a Better Dividend Stock SMMNY or CVAC?
Siemens Healthineers AG has a quarterly dividend of $0.59 per share corresponding to a yield of 2.9%. CureVac NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 34.75% of its earnings as a dividend. CureVac NV pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or CVAC?
Siemens Healthineers AG quarterly revenues are $6.3B, which are larger than CureVac NV quarterly revenues of $63.3M. Siemens Healthineers AG's net income of $530.8M is higher than CureVac NV's net income of $319.3M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 19.21x while CureVac NV's PE ratio is 6.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 1.75x versus 12.94x for CureVac NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG1.75x 19.21x $6.3B $530.8M CVACCureVac NV12.94x 6.52x $63.3M $319.3M
-
Which has Higher Returns SMMNY or IFRX?
InflaRx NV has a net margin of 8.44% compared to Siemens Healthineers AG's net margin of -51538.49%. Siemens Healthineers AG's return on equity of 11.6% beat InflaRx NV's return on equity of -82.01%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG38.43% $0.23 $38.9B IFRXInflaRx NV-320.86% -$0.21 $54.4M -
What do Analysts Say About SMMNY or IFRX?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand InflaRx NV has an analysts' consensus of $8.84 which suggests that it could grow by 868.56%. Given that InflaRx NV has higher upside potential than Siemens Healthineers AG, analysts believe InflaRx NV is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 IFRXInflaRx NV5 2 0 -
Is SMMNY or IFRX More Risky?
Siemens Healthineers AG has a beta of 1.171, which suggesting that the stock is 17.066% more volatile than S&P 500. In comparison InflaRx NV has a beta of 1.493, suggesting its more volatile than the S&P 500 by 49.333%.
-
Which is a Better Dividend Stock SMMNY or IFRX?
Siemens Healthineers AG has a quarterly dividend of $0.59 per share corresponding to a yield of 2.9%. InflaRx NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 34.75% of its earnings as a dividend. InflaRx NV pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or IFRX?
Siemens Healthineers AG quarterly revenues are $6.3B, which are larger than InflaRx NV quarterly revenues of $27.8K. Siemens Healthineers AG's net income of $530.8M is higher than InflaRx NV's net income of -$14.3M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 19.21x while InflaRx NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 1.75x versus 281.78x for InflaRx NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG1.75x 19.21x $6.3B $530.8M IFRXInflaRx NV281.78x -- $27.8K -$14.3M
-
Which has Higher Returns SMMNY or IMTX?
Immatics NV has a net margin of 8.44% compared to Siemens Healthineers AG's net margin of -180.65%. Siemens Healthineers AG's return on equity of 11.6% beat Immatics NV's return on equity of -40.01%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG38.43% $0.23 $38.9B IMTXImmatics NV-- -$0.33 $586.9M -
What do Analysts Say About SMMNY or IMTX?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Immatics NV has an analysts' consensus of $18.75 which suggests that it could grow by 81.16%. Given that Immatics NV has higher upside potential than Siemens Healthineers AG, analysts believe Immatics NV is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 IMTXImmatics NV9 0 0 -
Is SMMNY or IMTX More Risky?
Siemens Healthineers AG has a beta of 1.171, which suggesting that the stock is 17.066% more volatile than S&P 500. In comparison Immatics NV has a beta of 1.337, suggesting its more volatile than the S&P 500 by 33.675%.
-
Which is a Better Dividend Stock SMMNY or IMTX?
Siemens Healthineers AG has a quarterly dividend of $0.59 per share corresponding to a yield of 2.9%. Immatics NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 34.75% of its earnings as a dividend. Immatics NV pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or IMTX?
Siemens Healthineers AG quarterly revenues are $6.3B, which are larger than Immatics NV quarterly revenues of $23M. Siemens Healthineers AG's net income of $530.8M is higher than Immatics NV's net income of -$41.6M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 19.21x while Immatics NV's PE ratio is 42.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 1.75x versus 24.29x for Immatics NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG1.75x 19.21x $6.3B $530.8M IMTXImmatics NV24.29x 42.21x $23M -$41.6M
-
Which has Higher Returns SMMNY or MDGEF?
Medigene AG has a net margin of 8.44% compared to Siemens Healthineers AG's net margin of --. Siemens Healthineers AG's return on equity of 11.6% beat Medigene AG's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG38.43% $0.23 $38.9B MDGEFMedigene AG-- -- -- -
What do Analysts Say About SMMNY or MDGEF?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Medigene AG has an analysts' consensus of -- which suggests that it could fall by --. Given that Siemens Healthineers AG has higher upside potential than Medigene AG, analysts believe Siemens Healthineers AG is more attractive than Medigene AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 MDGEFMedigene AG0 0 0 -
Is SMMNY or MDGEF More Risky?
Siemens Healthineers AG has a beta of 1.171, which suggesting that the stock is 17.066% more volatile than S&P 500. In comparison Medigene AG has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SMMNY or MDGEF?
Siemens Healthineers AG has a quarterly dividend of $0.59 per share corresponding to a yield of 2.9%. Medigene AG offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 34.75% of its earnings as a dividend. Medigene AG pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or MDGEF?
Siemens Healthineers AG quarterly revenues are $6.3B, which are larger than Medigene AG quarterly revenues of --. Siemens Healthineers AG's net income of $530.8M is higher than Medigene AG's net income of --. Notably, Siemens Healthineers AG's price-to-earnings ratio is 19.21x while Medigene AG's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 1.75x versus -- for Medigene AG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG1.75x 19.21x $6.3B $530.8M MDGEFMedigene AG-- -- -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 4
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 4
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 4
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
